KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Short-Term Debt issuances (2016)

Novavax has reported Short-Term Debt issuances over the past 7 years, most recently at -$350000.0 for Q3 2016.

  • Quarterly results put Short-Term Debt issuances at -$350000.0 for Q3 2016, down 144.76% from a year ago — trailing twelve months through Sep 2017 was -$350000.0 (up 52.57% YoY), and the annual figure for FY2016 was -$395000.0, up 34.17%.
  • Short-Term Debt issuances for Q3 2016 was -$350000.0 at Novavax, down from -$103000.0 in the prior quarter.
  • Over the last five years, Short-Term Debt issuances for NVAX hit a ceiling of -$7000.0 in Q2 2012 and a floor of -$350000.0 in Q3 2016.
  • Median Short-Term Debt issuances over the past 5 years was -$147000.0 (2015), compared with a mean of -$133333.3.
  • Biggest five-year swings in Short-Term Debt issuances: surged 65.0% in 2012 and later tumbled 1285.71% in 2013.
  • Novavax's Short-Term Debt issuances stood at -$40000.0 in 2012, then crashed by 320.0% to -$168000.0 in 2013, then grew by 1.19% to -$166000.0 in 2014, then rose by 14.46% to -$142000.0 in 2015, then crashed by 146.48% to -$350000.0 in 2016.
  • The last three reported values for Short-Term Debt issuances were -$350000.0 (Q3 2016), -$103000.0 (Q2 2016), and -$143000.0 (Q1 2016) per Business Quant data.